BioSpace News Archive

Leveraging digital channels to connect with healthcare professionals is a top priority across the life sciences industry.

Vapotherm, Inc. announced that its management team will be presenting at the William Blair 40th Annual Growth Stock Conference on Wednesday, June 10, 2020 via webcast.

Pivotal trial demonstrated avacopan’s statistical superiority in sustaining remission at 52 weeks over the glucocorticoid-containing standard-of-care therapy

Replimune Group, Inc., a biotechnology company developing a series of oncolytic immuno-gene therapies derived from its Immulytic™ platform, announced financial results for the fiscal fourth quarter and year ended March 31, 2020 and provided a business update.

First-in-class, advanced diffusion optics technology spectacle lenses hailed as revolutionary innovation in myopia management

PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Primo” or the “Company”) is pleased to announce that it has signed a non-binding letter of intent (“LOI”) to provide funding and to acquire up to 100% of the assets and inventory of World Agri Minerals Ltd. (“WAM”), together (the “Parties”

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, announced CEO Dr. Pnina Fishman will share insight into the company’s recent developments and upcoming milestones during an investor webinar on Thursday, June 4th, 2020 at 11:00 a.m. ET.

Findings from open-label switch period of Early AMPLE study show that high efficacy responses observed at week 24 with Orencia were sustained through week 48 in early rheumatoid arthritis patients testing positive (seropositive) for certain autoantibodies

AlivaMab Discovery Services, LLC, a leader in comprehensive, integrated solutions for antibody drug discovery, announced a discovery partnership with Tanabe Research Laboratories USA, Inc. (TRL, San Diego, California), an independent subsidiary of Japan-based Mitsubishi Tanabe Pharma Corporation.

Novanta to Present at the William Blair 40 th Annual Growth Stock Conference on Tuesday, June 9, 2020